FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

Monroe Capital Provides $75MM Credit Facility to Alora Pharmaceuticals

September 17, 2013, 07:57 AM
Filed Under: Pharmaceuticals

Monroe Capital LLC announced the funding of a $75 million senior secured credit facility to support the growth of Alora Pharmaceuticals, LLC ("Alora"), the parent company of Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC.

Based in Alpharetta, Georgia, Alora develops and manufactures pharmaceuticals, including prenatal vitamins, nutraceuticals, dermatologics and innovative products for gastroenterology and endocrinology disorders. Alora maintains a broad portfolio of both branded and non-branded products, focusing on identifying opportunities to acquire and enhance the market potential of commercially available dietary supplement products and late-stage development drugs to fulfill unmet medical and dietary needs. Alora's flagship product, Prenate(R) is a leading brand name in the prescription prenatal vitamin market.

Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments.







Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.